Skip to main content
. 2025 Aug 6;38:14940. doi: 10.3389/ti.2025.14940

TABLE 2.

Multivariable Cox regression model for long-term graft survival, pooled from 20 imputed datasets. For restricted cubic splines see Figure 4 and Supplementary Figure S1.

Variable Hazard ratio (95% CI) P value
Donor age 1.011 (0.996–1.026) 0.164
Donor BMI 0.991 (0.960–1.024) 0.607
Donor cause of death
    Head trauma Ref
    Drug overdose 0.860 (0.601–1.231) 0.411
    Other 0.763 (0.577–1.008) 0.057
Donor type
    DBD Ref
    DCD 1.218 (0.613–2.418) 0.573
Pancreas preservation time 0.986 (0.956–1.016) 0.359
HLA Mismatch 0.950 (0.848–1.065) 0.380
CMV Match
    P/N = Yes Ref
    P/N = No 0.812 (0.620–1.062) 0.129
Duct management
    Enteric Drainage Ref
    Bladder Drainage 1.608 (0.920–2.809) 0.095
    Other 1.171 (0.688–1.995) 0.561
Steroids maintenance
    Yes Ref
    No 0.966 (0.732–1.276) 0.810
Donor ethnicity
    Black Ref
    White 0.996 (0.734–1.351) 0.979
    Other 0.946 (0.664–1.350) 0.761
Recipient BMI 1.004 (0.972–1.038) 0.809
cPRA
    <20 Ref
    ≥20 1.069 (0.790–1.447) 0.664
Recipient diabetes type
    Type 1 Ref
    Type 2 1.170 (0.849–1.612) 0.338
Previous pancreas transplant recipient
    No Ref
    Yes 0.706 (0.165–3.016) 0.639
Recipient on dialysis
    No Ref
    Yes 1.545 (1.123–2.126) 0.008
Treated for pancreas rejection in first year
    No Ref
    Yes 1.744 (1.201–2.532) 0.003
Treated for kidney rejection in first year
    No Ref
    Yes 1.118 (0.736–1.697) 0.601
RCS: Recipient age RCS terms 0.010
RCS: HbA1c at first year follow-up RCS terms <0.001
RCS: C-Peptide at first year follow-up RCS terms 0.034
RCS: eGFR at first year follow-up RCS terms <0.001

BMI, Body mass index; cPRA, Calculated panel reactive antibody; CMV, Cytomegalovirus; DBD, Donation after brain death; DCD, Donation after circulatory death; eGFR, Glomerular filtration rate; HbA1c, Glycosylated hemoglobin; HLA, Human leukocyte antigen; P/N, Donor positive, recipient negative; RCS, Restricted cubic splines.